andrew huberman glp 1 GLP-1 and Hunger Dr Andrew Huberman notes a
Description
Sarah Mess.
Online health startup Ro is getting into weight loss medicine, offering patients the trending obesity and diabetes GLP-1 class of drugs and real-time tracking.

In conclusion, the benefits of GLP-1RAs in MASLD are promising, and background therapy involving metabolic modulation may represent one of the future therapeutic paradigms.

Doctors in the US are not clear on what is causing the side effect, but say that it has been linked to rapid weight loss.
This is something a lot of people are asking
Triple agonist (GLP-1/GIP/Glucagon), under clinical investigation